We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2263 for:    SUSTAIN 1
Previous Study | Return to List | Next Study

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes (SUSTAIN™1)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02054897
First Posted: February 4, 2014
Last Update Posted: November 17, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Novo Nordisk A/S
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 8, 2015
  Primary Completion Date: May 8, 2015 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: March 17, 2016
Publications: